Description
Exemestane, sold under the brand name Exetraz, It is licensed for the treatment of breast cancer. Exemestane is available as a generic medicine in the India.
What is Exemestane Tablets used for?
Exetraz (Exemestane) contain Exemestane which belongs to a group of medicine called aromatase inhibitors. It is used to treat hormone dependent early breast cancer in postmenopausal women after they have completed 2-3 years of treatment with the medicine tamoxifen and hormone dependent advanced breast cancer in postmenopausal women when a different hormonal drugs treatment has not worked well enough.
How to buy Exetraz, the generic version of Exemestane Tablet in India or Globally?
Note: ” Exetraz, the generic version of “Exemestane Tablet” is accessible in India and can be delivered nationwide by Aark Pharmaceuticals. Exemestane Tablet is a medication that requires a prescription. Doxorubicin Injection is procurable through Aark Pharmaceuticals, based in Delhi, India, who are authorized suppliers of this product nationwide. We have delivered the medications to following cities in India – Bengaluru, Delhi, Ghaziabad, Noida, Gurugram, Chennai, Hyderabad, Mumbai, Pune, Kolkata, and Ahmedabad.. We are committed to delivering 100% authentic products to patients, doctors, and pharmacies. For further details, please contact us at +91-9999156233 or 011-40743520/21/22/23/24 or you can drop an email to us at sales@aarkpharma.com.
List of available and accessible generic brand of Exemestane Tablet?
Generic brand of Exemestane Tablet available and accessible to patients at an affordable price, at the earliest possible time: Xtane, Xmalon, Xcel, Exetraz, Aromasin
NEWS / Updates
- Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial
- Exemestane Plus Ovarian Suppression Best in Early Invasive Lobular Carcinoma
- Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Written By
Mr. Sandeep Tomar (D. pharma)
Last updated
01 Oct 2024 | 07:25 AM (IST)